4SC AG - Product Pipeline Review - 2016 - Global Markets Direct - Market Research

4SC AG - Product Pipeline Review - 2016

4SC AG - Product Pipeline Review - 2016 - Global Markets Direct - Market Research
4SC AG - Product Pipeline Review - 2016
Published Jul 20, 2016
51 pages — Published Jul 20, 2016
Price US$ 1,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, 4SC AG - Product Pipeline Review - 2016, provides an overview of the 4SC AGs pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by 4SC AG, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of 4SC AG
- The report provides overview of 4SC AG including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses 4SC AGs pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features 4SC AGs out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate 4SC AGs strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for 4SC AG
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding 4SC AGs pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

  
Source:
Document ID
GMDHC08096CDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables41
  List of Figures41
4SC AG Snapshot51
  4SC AG Overview51
  Key Information51
  Key Facts51
4SC AG Research and Development Overview63
  Key Therapeutic Areas63
4SC AG Pipeline Review94
  Pipeline Products by Stage of Development91
  Pipeline Products Monotherapy101
  Pipeline Products Partnered Products111
    Partnered Products/Combination Treatment Modalities121
4SC AG Pipeline Products Glance134
  4SC AG Clinical Stage Pipeline Products131
    Phase II Products/Combination Treatment Modalities131
    Phase I Products/Combination Treatment Modalities141
  4SC AG Early Stage Pipeline Products151
    Preclinical Products/Combination Treatment Modalities151
    Discovery Products/Combination Treatment Modalities161
4SC AG Drug Profiles1717
  resminostat171
    Product Description171
    Mechanism of Action171
    R&D Progress176
  vidofludimus231
    Product Description231
    Mechanism of Action231
    R&D Progress234
  4SC-202271
    Product Description271
    Mechanism of Action271
    R&D Progress272
  4SC-205291
    Product Description291
    Mechanism of Action291
    R&D Progress292
  Small Molecule for Malaria311
    Product Description311
    Mechanism of Action311
    R&D Progress311
  Small Molecules for Neurological Disorders321
    Product Description321
    Mechanism of Action321
    R&D Progress321
  Small Molecules to Inhibit Bromodomain for Cancer331
    Product Description331
    Mechanism of Action331
    R&D Progress331
4SC AG Pipeline Analysis344
  4SC AG Pipeline Products by Target341
  4SC AG Pipeline Products by Route of Administration351
  4SC AG Pipeline Products by Molecule Type361
  4SC AG Pipeline Products by Mechanism of Action371
4SC AG Recent Pipeline Updates387
4SC AG Dormant Projects451
4SC AG Discontinued Pipeline Products461
  Discontinued Pipeline Product Profiles461
    4SC-203461
    4SC-207461
    resminostat461
4SC AG Company Statement472
4SC AG Locations And Subsidiaries491
  Head Office491
Appendix502
  Methodology501
  Coverage501
  Secondary Research501
  Primary Research501
  Expert Panel Validation501
  Contact Us501
  Disclaimer511

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "4SC AG - Product Pipeline Review - 2016" Jul 20, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/4SC-AG-Product-Pipeline-Review-2016-2088-16204>
  
APA:
Global Markets Direct - Market Research. (2016). 4SC AG - Product Pipeline Review - 2016 Jul 20, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/4SC-AG-Product-Pipeline-Review-2016-2088-16204>
  
US$ 1,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.